BioLineRX Ltd BLRX
$2.93
+2.81%
at last close
Analyst Consensus
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2025-06-17 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $26 |
| 2025-05-30 | Jones TradingJustin Walsh |
Upgrades | Hold → Buy | $12 |
| 2025-05-28 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $26 |
| 2025-04-02 | Jones TradingJustin Walsh |
Downgrades | Buy → Hold | — |
| 2025-03-31 | HC Wainwright & Co.Joseph Pantginis |
Maintains | Buy | $9 → $26 |
| 2024-11-25 | HC Wainwright & Co.Joseph Pantginis |
Maintains | Buy | $840 → $360 |
| 2024-11-06 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $840 |
| 2024-09-04 | Jones TradingJustin Walsh |
Initiates coverage on | Buy | $80 |
| 2024-06-03 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $840 |
| 2024-05-29 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $840 |
| 2024-04-17 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $840 |
| 2024-03-26 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $840 |
| 2024-02-29 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $840 |
| 2023-11-20 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $840 |
| 2023-09-15 | HC Wainwright & Co.Joseph Pantginis |
Maintains | Buy | $760 → $840 |
| 2023-08-31 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $760 |
| 2023-05-25 | OppenheimerMark Breidenbach |
Reiterates | Outperform | $160 |
| 2021-02-23 | HC Wainwright & Co.Joseph Pantginis |
Maintains | Buy | $880 → $760 |
| 2020-12-16 | HC Wainwright & Co. |
Maintains | Buy | $720 → $880 |
| 2017-08-04 | Oppenheimer |
Initiates coverage on | Outperform | $1800 |
| 2017-05-18 | Maxim GroupJason Kolbert |
Upgrades | Hold → Buy | — |
| 2017-02-13 | Rodman & Renshaw |
Initiates coverage on | Buy | $1800 |
| 2016-08-12 | Maxim GroupJason Kolbert |
Downgrades | Buy → Hold | — |
| 2016-03-09 | JMP Securities |
Maintains | Market outperform | $2100 → $1800 |
| 2015-06-22 | JMP Securities |
Initiates coverage on | Outperform | $3000 |
| 2015-06-22 | JP Morgan |
Initiates coverage on | Market outperform | $3000 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $2.93
- Market Cap
- $12.40 million
- 52-Week Range
- $2.15 – $4.75
- Average Volume
- 9K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.